当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2021-05-04 , DOI: 10.1021/acs.jmedchem.1c00542
Younho Lee 1, 2 , Hyunkyung Kim 2, 3 , Haelee Kim 4 , Ha Yeon Cho 4 , Jun-Goo Jee 3 , Kyung-Ah Seo 2 , Jung Beom Son 2 , Eunhwa Ko 4 , Hwan Geun Choi 4 , Nam Doo Kim 2 , Ikyon Kim 1
Affiliation  

Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity protein kinase that is over-expressed in TNBC. We herein report a highly selective MPS1 inhibitor based on a 7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile scaffold. Our lead optimization was guided by key X-ray crystal structure analysis. In vivo evaluation of candidate (9) is shown to effectively mitigate human TNBC cell proliferation.

中文翻译:

X射线晶体结构指导的7 H-吡咯并[2,3 - d ]嘧啶-5-腈骨架作为有效的口服活性单极纺锤体1抑制剂的设计与优化

三阴性乳腺癌(TNBC)是一种侵袭性乳腺癌亚型,与不良预后和高复发率相关。单极纺锤体1激酶(MPS1)是一种顶端双特异性蛋白激酶,在TNBC中过表达。我们在此报告了一种基于7 H-吡咯并[2,3 - d ]嘧啶-5-腈骨架的高选择性MPS1抑制剂。我们的铅优化是通过关键的X射线晶体结构分析进行的。候选物的体内评估(9)显示可有效缓解人TNBC细胞增殖。
更新日期:2021-05-27
down
wechat
bug